United States - English - NLM (National Library of Medicine)

e.r. squibb & sons, l.l.c. - belatacept (unii: e3b2gi648a) (belatacept - unii:e3b2gi648a) - belatacept 250 mg - nulojix® (belatacept) is indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant. nulojix is to be used in combination with basiliximab induction, mycophenolate mofetil, and corticosteroids. use nulojix only in patients who are ebv seropositive [see contraindications (4) and warnings and precautions (5.1)] . use of nulojix for the prophylaxis of organ rejection in transplanted organs other than kidney has not been established [see warnings and precautions (5.6)] . nulojix is contraindicated in transplant recipients who are epstein-barr virus (ebv) seronegative or with unknown ebv serostatus due to the risk of post-transplant lymphoproliferative disorder (ptld), predominantly involving the central nervous system (cns) [see boxed warning and warnings and precautions (5.1)] . to monitor maternal-fetal outcomes of pregnant women who have received immunosuppressants including nulojix or whose partners have received nulojix, healthcare providers are strongly encouraged to regis

European Union - English - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - immunosuppressants - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant. 

Australia - English - Department of Health (Therapeutic Goods Administration)

bristol-myers squibb australia pty ltd - belatacept, quantity: 250 mg - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; monobasic sodium phosphate; sucrose; nitrogen; sodium hydroxide; sodium chloride - nulojix (belatacept) is indicated for prophylaxis of organ rejection in adults receiving a renal transplant. nulojix is to be used in combination with basiliximab induction, mycophenolate mofetil, and corticosteroids.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma (m) sdn. bhd. - latanoprost; timolol maleate -

Ireland - English - HPRA (Health Products Regulatory Authority)

ntc srl - latanoprost - eye drops, solution - 50 microgram(s)/millilitre - prostaglandin analogues1); latanoprost

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - belatacept - powder for solution for infusion - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dermal laboratories ltd - salicylic acid; lactic acid - cutaneous gel - 120mg/1gram ; 40mg/1gram

Ireland - English - HPRA (Health Products Regulatory Authority)

dermal laboratories (ireland) limited - salicylic acid; lactic acid - gel - 12.0 %w/w + 4.0 percent weight/weight - wart and anti-corn preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

dermal laboratories ltd - salicylic acid; lactic acid - gel - 12.0 %w/w + 4.0 percent weight/weight - wart and anti-corn preparations

Israel - English - Ministry of Health

trupharm marketing 1985 ltd. - lactic acid; salicylic acid - gel - salicylic acid 12 %w/w; lactic acid 4 %w/w - salicylic acid - salicylic acid - for topical treatment of warts, corns or callouses.